From the Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.
Pediatr Infect Dis J. 2020 May;39(5):438-443. doi: 10.1097/INF.0000000000002590.
Suspected early-onset sepsis (EOS) results in antibiotic treatment of a substantial number of neonates who are uninfected. We evaluated if an approach using serial physical examinations (SPEs) can reduce antibiotic exposure for suspected EOS in term neonates during the first 3 days of life, without affecting safety.
Within a quality-improvement framework, SPEs for 24-48 hours for neonates with suspected EOS was implemented in the neonatal intensive care unit, Stavanger, Norway. The proportion of neonates ≥37 weeks gestation exposed to antibiotics, antibiotic therapy-days and the safety outcome time from birth to start antibiotics were compared between a baseline period (April 2014-February 2016), when a risk factor based approach was used, and a post-SPE-implementation period (January 2017-November 2018).
We included all term live born neonates (n = 17,242) in the 2 periods. There was a 57% relative reduction in neonates exposed to antibiotics; 2.9% in the baseline and 1.3% in the post-implementation period, P < 0.001. There was a 60% relative reduction in mean antibiotic therapy-days/1000 patient-days; from 320 to 129, P < 0.001, and a 50% relative reduction in time to initiate antibiotics in suspected EOS-cases, from median (interquartile range) 14 (5-28) to 7 (3-17) hours, P = 0.003. The incidence of culture-positive EOS remained unchanged. There were no infection-attributable deaths.
Implementing SPE to guide empiric antibiotic therapy in term neonates with suspected EOS more than halved the burden of antibiotic exposure, without delay of antibiotic treatment of infected neonates or increased sepsis-related mortality.
疑似早发型败血症(EOS)导致大量未感染的新生儿接受抗生素治疗。我们评估了在生命的头 3 天内,使用连续体格检查(SPEs)是否可以减少足月新生儿疑似 EOS 中抗生素的暴露,同时不影响安全性。
在质量改进框架内,对挪威斯塔万格新生儿重症监护病房疑似 EOS 的新生儿实施了 24-48 小时的 SPEs。比较了基于风险因素的方法(基线期:2014 年 4 月至 2016 年 2 月)和 SPE 实施后的时期(2017 年 1 月至 2018 年 11 月),比较了暴露于抗生素的新生儿比例、抗生素治疗天数和从出生到开始使用抗生素的安全结果时间。
我们纳入了两个时期的所有足月活产新生儿(n=17242)。暴露于抗生素的新生儿相对减少了 57%;基线期为 2.9%,实施后为 1.3%,P<0.001。平均抗生素治疗天数/1000 患者天数相对减少了 60%;从 320 减少到 129,P<0.001,疑似 EOS 病例中开始使用抗生素的时间相对减少了 50%;中位数(四分位数间距)从 14(5-28)减少到 7(3-17)小时,P=0.003。阳性培养 EOS 的发生率保持不变。没有与感染相关的死亡。
在疑似 EOS 的足月新生儿中实施 SPE 以指导经验性抗生素治疗,使抗生素暴露负担减少了一半以上,同时不会延迟感染新生儿的抗生素治疗或增加与败血症相关的死亡率。